Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
87
CLBR Quote, Financials, Valuation and Earnings
Last price:
$17.24
Seasonality move
:
0.08%
Day range:
$15.25 - $18.00
52-week range:
$10.15 - $18.45
Dividend yield:
0%
P/E ratio:
86.20x
P/S ratio:
--
P/B ratio:
2.13x
Volume:
4.8M
Avg. volume:
1.9M
1-year change:
67.38%
Market cap:
$366.4M
Revenue:
--
EPS (TTM):
$0.20
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
CLBR
Colombier Acquisition Corp II
|
-- | -- | -- | -- | -- |
|
CCAP
Crescent Capital BDC
|
$42.5M | $0.47 | 85.64% | -14.91% | $17.33 |
|
DMYY
dMY Squared Technology Group
|
-- | -- | -- | -- | -- |
|
FHLT
Future Health ESG
|
-- | -- | -- | -- | -- |
|
GRAF
Graf Global
|
-- | -- | -- | -- | -- |
|
LEGT
Legato Merger Corp III
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
CLBR
Colombier Acquisition Corp II
|
$17.24 | -- | $366.4M | 86.20x | $0.00 | 0% | -- |
|
CCAP
Crescent Capital BDC
|
$14.65 | $17.33 | $543M | 10.93x | $0.42 | 12.56% | 8.97x |
|
DMYY
dMY Squared Technology Group
|
$12.56 | -- | $49.2M | 59.33x | $0.00 | 0% | -- |
|
FHLT
Future Health ESG
|
$10.96 | -- | $65.1M | -- | $0.00 | 0% | -- |
|
GRAF
Graf Global
|
$10.47 | -- | $301M | 39.46x | $0.00 | 0% | -- |
|
LEGT
Legato Merger Corp III
|
$10.72 | -- | $276.6M | 29.78x | $0.00 | 0% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
CLBR
Colombier Acquisition Corp II
|
-- | 0.502 | -- | -- |
|
CCAP
Crescent Capital BDC
|
55.39% | 0.392 | 142.31% | 0.62x |
|
DMYY
dMY Squared Technology Group
|
-- | -0.068 | -- | -- |
|
FHLT
Future Health ESG
|
-- | 0.000 | -- | -- |
|
GRAF
Graf Global
|
-- | 0.000 | -- | -- |
|
LEGT
Legato Merger Corp III
|
-- | -0.025 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
CLBR
Colombier Acquisition Corp II
|
-- | -$1.9M | -- | -- | -- | -$462.4K |
|
CCAP
Crescent Capital BDC
|
-- | -- | 3.07% | 6.66% | 254.33% | -$15.1M |
|
DMYY
dMY Squared Technology Group
|
-- | -$492.2K | -- | -- | -- | -$773.6K |
|
FHLT
Future Health ESG
|
-- | -- | -- | -- | -- | -- |
|
GRAF
Graf Global
|
-- | -$273.2K | -- | -- | -- | -$119.5K |
|
LEGT
Legato Merger Corp III
|
-- | -$167.1K | -- | -- | -- | -$86.2K |
Colombier Acquisition Corp II vs. Competitors
-
Which has Higher Returns CLBR or CCAP?
Crescent Capital BDC has a net margin of -- compared to Colombier Acquisition Corp II's net margin of 54.76%. Colombier Acquisition Corp II's return on equity of -- beat Crescent Capital BDC's return on equity of 6.66%.
Company Gross Margin Earnings Per Share Invested Capital CLBRColombier Acquisition Corp II-- -- -- CCAPCrescent Capital BDC-- $0.11 $1.6B -
What do Analysts Say About CLBR or CCAP?
Colombier Acquisition Corp II has a consensus price target of --, signalling downside risk potential of --. On the other hand Crescent Capital BDC has an analysts' consensus of $17.33 which suggests that it could grow by 18.32%. Given that Crescent Capital BDC has higher upside potential than Colombier Acquisition Corp II, analysts believe Crescent Capital BDC is more attractive than Colombier Acquisition Corp II.
Company Buy Ratings Hold Ratings Sell Ratings CLBRColombier Acquisition Corp II0 0 0 CCAPCrescent Capital BDC3 2 0 -
Is CLBR or CCAP More Risky?
Colombier Acquisition Corp II has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Crescent Capital BDC has a beta of 0.522, suggesting its less volatile than the S&P 500 by 47.848%.
-
Which is a Better Dividend Stock CLBR or CCAP?
Colombier Acquisition Corp II has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Crescent Capital BDC offers a yield of 12.56% to investors and pays a quarterly dividend of $0.42 per share. Colombier Acquisition Corp II pays -- of its earnings as a dividend. Crescent Capital BDC pays out 102.15% of its earnings as a dividend.
-
Which has Better Financial Ratios CLBR or CCAP?
Colombier Acquisition Corp II quarterly revenues are --, which are smaller than Crescent Capital BDC quarterly revenues of $7.1M. Colombier Acquisition Corp II's net income of -$49K is lower than Crescent Capital BDC's net income of $3.9M. Notably, Colombier Acquisition Corp II's price-to-earnings ratio is 86.20x while Crescent Capital BDC's PE ratio is 10.93x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Colombier Acquisition Corp II is -- versus 8.97x for Crescent Capital BDC. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CLBRColombier Acquisition Corp II-- 86.20x -- -$49K CCAPCrescent Capital BDC8.97x 10.93x $7.1M $3.9M
-
Which has Higher Returns CLBR or DMYY?
dMY Squared Technology Group has a net margin of -- compared to Colombier Acquisition Corp II's net margin of --. Colombier Acquisition Corp II's return on equity of -- beat dMY Squared Technology Group's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital CLBRColombier Acquisition Corp II-- -- -- DMYYdMY Squared Technology Group-- -$1.16 -- -
What do Analysts Say About CLBR or DMYY?
Colombier Acquisition Corp II has a consensus price target of --, signalling downside risk potential of --. On the other hand dMY Squared Technology Group has an analysts' consensus of -- which suggests that it could fall by --. Given that Colombier Acquisition Corp II has higher upside potential than dMY Squared Technology Group, analysts believe Colombier Acquisition Corp II is more attractive than dMY Squared Technology Group.
Company Buy Ratings Hold Ratings Sell Ratings CLBRColombier Acquisition Corp II0 0 0 DMYYdMY Squared Technology Group0 0 0 -
Is CLBR or DMYY More Risky?
Colombier Acquisition Corp II has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison dMY Squared Technology Group has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock CLBR or DMYY?
Colombier Acquisition Corp II has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. dMY Squared Technology Group offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Colombier Acquisition Corp II pays -- of its earnings as a dividend. dMY Squared Technology Group pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios CLBR or DMYY?
Colombier Acquisition Corp II quarterly revenues are --, which are smaller than dMY Squared Technology Group quarterly revenues of --. Colombier Acquisition Corp II's net income of -$49K is higher than dMY Squared Technology Group's net income of -$4.6M. Notably, Colombier Acquisition Corp II's price-to-earnings ratio is 86.20x while dMY Squared Technology Group's PE ratio is 59.33x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Colombier Acquisition Corp II is -- versus -- for dMY Squared Technology Group. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CLBRColombier Acquisition Corp II-- 86.20x -- -$49K DMYYdMY Squared Technology Group-- 59.33x -- -$4.6M
-
Which has Higher Returns CLBR or FHLT?
Future Health ESG has a net margin of -- compared to Colombier Acquisition Corp II's net margin of --. Colombier Acquisition Corp II's return on equity of -- beat Future Health ESG's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital CLBRColombier Acquisition Corp II-- -- -- FHLTFuture Health ESG-- -- -- -
What do Analysts Say About CLBR or FHLT?
Colombier Acquisition Corp II has a consensus price target of --, signalling downside risk potential of --. On the other hand Future Health ESG has an analysts' consensus of -- which suggests that it could fall by --. Given that Colombier Acquisition Corp II has higher upside potential than Future Health ESG, analysts believe Colombier Acquisition Corp II is more attractive than Future Health ESG.
Company Buy Ratings Hold Ratings Sell Ratings CLBRColombier Acquisition Corp II0 0 0 FHLTFuture Health ESG0 0 0 -
Is CLBR or FHLT More Risky?
Colombier Acquisition Corp II has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Future Health ESG has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock CLBR or FHLT?
Colombier Acquisition Corp II has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Future Health ESG offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Colombier Acquisition Corp II pays -- of its earnings as a dividend. Future Health ESG pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios CLBR or FHLT?
Colombier Acquisition Corp II quarterly revenues are --, which are smaller than Future Health ESG quarterly revenues of --. Colombier Acquisition Corp II's net income of -$49K is higher than Future Health ESG's net income of --. Notably, Colombier Acquisition Corp II's price-to-earnings ratio is 86.20x while Future Health ESG's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Colombier Acquisition Corp II is -- versus -- for Future Health ESG. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CLBRColombier Acquisition Corp II-- 86.20x -- -$49K FHLTFuture Health ESG-- -- -- --
-
Which has Higher Returns CLBR or GRAF?
Graf Global has a net margin of -- compared to Colombier Acquisition Corp II's net margin of --. Colombier Acquisition Corp II's return on equity of -- beat Graf Global's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital CLBRColombier Acquisition Corp II-- -- -- GRAFGraf Global-- $0.08 -- -
What do Analysts Say About CLBR or GRAF?
Colombier Acquisition Corp II has a consensus price target of --, signalling downside risk potential of --. On the other hand Graf Global has an analysts' consensus of -- which suggests that it could fall by --. Given that Colombier Acquisition Corp II has higher upside potential than Graf Global, analysts believe Colombier Acquisition Corp II is more attractive than Graf Global.
Company Buy Ratings Hold Ratings Sell Ratings CLBRColombier Acquisition Corp II0 0 0 GRAFGraf Global0 0 0 -
Is CLBR or GRAF More Risky?
Colombier Acquisition Corp II has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Graf Global has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock CLBR or GRAF?
Colombier Acquisition Corp II has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Graf Global offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Colombier Acquisition Corp II pays -- of its earnings as a dividend. Graf Global pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios CLBR or GRAF?
Colombier Acquisition Corp II quarterly revenues are --, which are smaller than Graf Global quarterly revenues of --. Colombier Acquisition Corp II's net income of -$49K is lower than Graf Global's net income of $2.2M. Notably, Colombier Acquisition Corp II's price-to-earnings ratio is 86.20x while Graf Global's PE ratio is 39.46x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Colombier Acquisition Corp II is -- versus -- for Graf Global. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CLBRColombier Acquisition Corp II-- 86.20x -- -$49K GRAFGraf Global-- 39.46x -- $2.2M
-
Which has Higher Returns CLBR or LEGT?
Legato Merger Corp III has a net margin of -- compared to Colombier Acquisition Corp II's net margin of --. Colombier Acquisition Corp II's return on equity of -- beat Legato Merger Corp III's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital CLBRColombier Acquisition Corp II-- -- -- LEGTLegato Merger Corp III-- $0.08 -- -
What do Analysts Say About CLBR or LEGT?
Colombier Acquisition Corp II has a consensus price target of --, signalling downside risk potential of --. On the other hand Legato Merger Corp III has an analysts' consensus of -- which suggests that it could fall by --. Given that Colombier Acquisition Corp II has higher upside potential than Legato Merger Corp III, analysts believe Colombier Acquisition Corp II is more attractive than Legato Merger Corp III.
Company Buy Ratings Hold Ratings Sell Ratings CLBRColombier Acquisition Corp II0 0 0 LEGTLegato Merger Corp III0 0 0 -
Is CLBR or LEGT More Risky?
Colombier Acquisition Corp II has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Legato Merger Corp III has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock CLBR or LEGT?
Colombier Acquisition Corp II has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Legato Merger Corp III offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Colombier Acquisition Corp II pays -- of its earnings as a dividend. Legato Merger Corp III pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios CLBR or LEGT?
Colombier Acquisition Corp II quarterly revenues are --, which are smaller than Legato Merger Corp III quarterly revenues of --. Colombier Acquisition Corp II's net income of -$49K is lower than Legato Merger Corp III's net income of $2.1M. Notably, Colombier Acquisition Corp II's price-to-earnings ratio is 86.20x while Legato Merger Corp III's PE ratio is 29.78x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Colombier Acquisition Corp II is -- versus -- for Legato Merger Corp III. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CLBRColombier Acquisition Corp II-- 86.20x -- -$49K LEGTLegato Merger Corp III-- 29.78x -- $2.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is up 0.54% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.77% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 8.52% over the past day.
